Orthocell receives $2.9 million R&D refund

Nerve technology developer Orthocell (ASX:OCC) has received a $2.9 million R&D tax incentive refund for the 2018/19 financial year. The Perth company, which is commercialising its CelGro product to facilitate the regeneration of severed peripheral nerves, will invest the funds to accelerate regulatory approvals and to advance R&D. The company also recently raised new capital…

Australian Vanadium in talks with Chinese steelmaker

Resources and chemicals group Australian Vanadium (ASX: AVL) has signed an agreement which could see its services and products sold into the China market. The company, which is developing large-scale vanadium deposits and manufactures vanadium battery electrolyte, signed agreements with Hebei Yanshan Vanadium and Titanium Industry Technology Research Co to allow the negotiation of a…

NW Tasmania fish food factory to begin commissioning next month

The BioMar Australia aqua feed mill in Tasmania’s north-west is on schedule to open in April, according to the company, with the site to employ 55 and have an annual capacity of 110,000 tonnes. The Advocate reports that commissioning at the Wesley Vale site is expected to begin “dry commissioning” in February, running machinery and…

Submarine deal’s sinking feeling – defence doubts revealed

Comment by Peter Roberts Australia’s $50 billion deal to buy submarines from the French Naval Grup looks to be on shakey ground with the release of a highly critical report from the Commonwealth Auditor-General. Far from being a great deal, the federal government began planning to walk away from the deal during the torturous negotiation…